Results 231 to 240 of about 17,806,092 (307)

Gatekeepers of the Future: The Role of Corporate Venture Capital in Corporate Artificial Intelligence Adoptions

open access: yesStrategic Change, EarlyView.
ABSTRACT This study extends absorptive capacity research by showing how corporate venture capital (CVC) investments enable corporate artificial intelligence (AI) adoption through collaboration pathways, delineated in four adoption archetypes that explain how heterogeneous AI knowledge is absorbed.
Louisa A. Müller   +2 more
wiley   +1 more source

SEN2COR für Sentinel-2

open access: yes, 2017
Main-Knorn, Magdalena, Pflug, Bringfried
openaire   +1 more source

Universal Risk Stratification in Stage I–III Cutaneous Melanoma Using 31‐gene Expression Profiling: A Single‐Center Study

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Patients with early‐stage cutaneous melanoma (CM) have low individual risk but account for most distant recurrences. The utility of gene expression profiling (GEP) in CM risk stratification and clinical management remains unclear. Methods From 2015 to 2022, CM patients at a single center were universally referred for DecisionDx 31 ...
Daniel B. Gehle   +10 more
wiley   +1 more source

Omission of Sentinel Lymph Node Biopsy in Breast Cancer: A Real‐World Validation of the Patient Populations of the SOUND and INSEMA Trials

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Treatment guidelines recommending omission of axillary surgery in breast cancer are largely based on the SOUND and INSEMA trials. However, the extent to which their study populations represent real‐world patients remains unclear.
Tia Puiras   +2 more
wiley   +1 more source

A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With Dupilumab

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 644-647, June 2026.
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy